Recall of Quality Choice Cough Drops Over Quality Concerns
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. is recalling certain lots of Quality Choice Menthol Cough Drops due to potential quality issues identified during an FDA inspection.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on May 3, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
The recall was initiated following FDA's recommendation based on observations noted during an August 15, 2025, inspection of the manufacturing facility that may affect product quality.
Which Products Are Affected
The affected product is QC Quality Choice, Menthol- Cough Suppressant Oral Anesthetic, Cough Drops, Cherry Flavor, 30-count bag, distributed by CDMA, Inc., Novi MI 48375, Made in China. It has NDC: 83698-616-25, UPC: 635515993372, and affects Lot # 20240524 with expiration date 05/24/2026, and Lot # 20240720 with expiration date 07/20/2026. The product quantity is not specified, and it was distributed US Nationwide.
What You Should Do
Consumers should contact the recalling firm, Xiamen Kang Zhongyuan Biotechnology Co., Ltd., at their address: No. 2018, 2 Jietou Road, for instructions on returns or refunds, as the recall was initiated via letter.
Why This Matters
This recall highlights potential quality issues with over-the-counter drugs, which could affect consumer safety and trust in the supply chain, though the FDA has classified it as Class II, indicating a remote probability of serious health consequences.
Source
Attribution: FDA. For more information, refer to the FDA recall notice with recall number D-0465-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,279 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to May 3, 2026.
Frequently Asked Questions
Common questions about this FDA recall.